For those using these products for weight loss only, it’s important to understand that these are not miracle drugs.

Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...

The ABC7 Chicago I-Team and ABC News are investigating the risks, and finding out how people are safely getting lower-cost ...

This copy is for your personal, non-commercial use only ... But for diabetes and obesity drugs like Ozempic and Zepbound, known as GLP-1s, cheaper copycats emerged almost immediately.

Huel counts Jonathan Ross and the actor Idris Elbas among its investors, alongside Steven Bartlett, the podcaster and former ...

We recently published a list of 12 Most Profitable Pharmaceutical Stocks Right Now. In this article, we are going to take a ...

One the bigger drivers of Medicaid’s rising costs is the ballooning expense of covering weight loss drugs, a state Senate Finance Committee review found.

The Biden administration proposes Medicare and Medicaid coverage for weight loss medications like Wegovy and Ozempic.

James McMaster, the company’s chief executive, said this had helped it appeal to a wider swathe of health-conscious consumers and that the rise of Ozempic ... to disclose a commercial relationship.

Novo Nordisk will report the topline results from the REDEFINE-1 trial of CagriSema in obese patients before the end of the ...

Amid ongoing concerns about the cost and supply of GLP-1s, a new study suggests that a wide swath of American adults would ...